Biomarkers for Liver Disease in Urea Cycle Disorders

Overview

Journal Mol Genet Metab

Specialty Endocrinology

Date 2021 Apr 13

PMID 33846069

Citations 7

Authors

Sandesh C S Nagamani

Saima Ali

Rima Izem

Deborah Schady

Prakash Masand

Benjamin L Shneider

Daniel H Leung

Lindsay C Burrage

Affiliations

Soon will be listed here.

Abstract

Background: Urea cycle disorders (UCDs) are among the most common inborn errors of liver metabolism. As therapies for hyperammonemia associated with urea cycle dysfunction have improved, chronic complications, such as liver disease, have become increasingly apparent in individuals with UCDs. Liver disease in UCDs may be associated with hepatic inflammation, hepatic fibrosis, portal hypertension, liver cancer and even liver failure. However, except for monitoring serum aminotransferases, there are no clear guidelines for screening and/or monitoring individuals with UCDs for liver disease. Thus, we systematically evaluated the potential utility of several non-invasive biomarkers for liver fibrosis in UCDs.

Methods: We evaluated grey-scale ultrasonography, liver stiffness obtained from shear wave elastography (SWE), and various serum biomarkers for hepatic fibrosis and necroinflammation, in a cohort of 28 children and adults with various UCDs.

Results: Overall, we demonstrate a high burden of liver disease in our participants with 46% of participants having abnormal grey-scale ultrasound pattern of the liver parenchyma, and 52% of individuals having increased liver stiffness. The analysis of serum biomarkers revealed that 32% of participants had elevated FibroTest™ score, a marker for hepatic fibrosis, and 25% of participants had increased ActiTest™ score, a marker for necroinflammation. Interestingly, liver stiffness did not correlate with ultrasound appearance or FibroTest™.

Conclusion: Overall, our results demonstrate the high overall burden of liver disease in UCDs and highlights the need for further studies exploring new tools for identifying and monitoring individuals with UCDs who are at risk for this complication.

Trial Registration: This study has been registered in ClinicalTrials.gov (NCT03721367).

Citing Articles

Hyperammonemia induces programmed liver cell death.

Kerbert A, Engelmann C, Habtesion A, Kumar P, Hassan M, Qi T Sci Adv. 2025; 11(10):eado1648.

PMID: 40053595 PMC: 11887801. DOI: 10.1126/sciadv.ado1648.

A novel Ala469Val variant resulting in glycerol kinase deficiency with concurrent hepatoblastoma: A case report.

Filingeri D, Mackey S, Soller H, Guarneri-Tragone A, Cooper J, Escobar O Mol Genet Metab Rep. 2024; 38:101058.

PMID: 38469098 PMC: 10926216. DOI: 10.1016/j.ymgmr.2024.101058.

New plasma diagnostic markers for colorectal cancer: transporter fragments of glutamate tRNA origin.

Ye C, Cheng F, Huang L, Wang K, Zhong L, Lu Y J Cancer. 2024; 15(5):1299-1313.

PMID: 38356701 PMC: 10861818. DOI: 10.7150/jca.92102.

mRNA therapy corrects defective glutathione metabolism and restores ureagenesis in preclinical argininosuccinic aciduria.

Gurung S, Timmermand O, Perocheau D, Gil-Martinez A, Minnion M, Touramanidou L Sci Transl Med. 2024; 16(729):eadh1334.

PMID: 38198573 PMC: 7615535. DOI: 10.1126/scitranslmed.adh1334.

The incidence of movement disorder increases with age and contrasts with subtle and limited neuroimaging abnormalities in argininosuccinic aciduria.

Gurung S, Karamched S, Perocheau D, Seunarine K, Baldwin T, Alrashidi H J Inherit Metab Dis. 2023; 47(6):1213-1227.

PMID: 38044746 PMC: 11586606. DOI: 10.1002/jimd.12691.

References

Trevisson E, Salviati L, Baldoin M, Toldo I, Casarin A, Sacconi S . Argininosuccinate lyase deficiency: mutational spectrum in Italian patients and identification of a novel ASL pseudogene. Hum Mutat. 2007; 28(7):694-702. DOI: 10.1002/humu.20498. View

Badizadegan K, Perez-Atayde A . Focal glycogenosis of the liver in disorders of ureagenesis: its occurrence and diagnostic significance. Hepatology. 1997; 26(2):365-73. DOI: 10.1002/hep.510260217. View

Ranucci G, Rigoldi M, Cotugno G, Bernabei S, Liguori A, Gasperini S . Chronic liver involvement in urea cycle disorders. J Inherit Metab Dis. 2019; 42(6):1118-1127. DOI: 10.1002/jimd.12144. View

Nasser Kabbany M, Selvakumar P, Watt K, Lopez R, Akras Z, Zein N . Prevalence of Nonalcoholic Steatohepatitis-Associated Cirrhosis in the United States: An Analysis of National Health and Nutrition Examination Survey Data. Am J Gastroenterol. 2017; 112(4):581-587. DOI: 10.1038/ajg.2017.5. View

Newnham T, Hardikar W, Allen K, Wellard R, Hamilton C, Angus P . Liver transplantation for argininosuccinic aciduria: clinical, biochemical, and metabolic outcome. Liver Transpl. 2007; 14(1):41-5. DOI: 10.1002/lt.21297. View

Zimmermann A, Bachmann C, Baumgartner R . Severe liver fibrosis in argininosuccinic aciduria. Arch Pathol Lab Med. 1986; 110(2):136-40. View

De Chiara F, Heeboll S, Marrone G, Montoliu C, Hamilton-Dutoit S, Ferrandez A . Urea cycle dysregulation in non-alcoholic fatty liver disease. J Hepatol. 2018; 69(4):905-915. DOI: 10.1016/j.jhep.2018.06.023. View

Summar M, Koelker S, Freedenberg D, Le Mons C, Haberle J, Lee H . The incidence of urea cycle disorders. Mol Genet Metab. 2013; 110(1-2):179-80. PMC: 4364413. DOI: 10.1016/j.ymgme.2013.07.008. View

Myers R, Ratziu V, Imbert-Bismut F, Charlotte F, Poynard T . Biochemical markers of liver fibrosis: a comparison with historical features in patients with chronic hepatitis C. Am J Gastroenterol. 2002; 97(9):2419-25. DOI: 10.1111/j.1572-0241.2002.05997.x. View

10.

Laemmle A, Gallagher R, Keogh A, Stricker T, Gautschi M, Nuoffer J . Frequency and Pathophysiology of Acute Liver Failure in Ornithine Transcarbamylase Deficiency (OTCD). PLoS One. 2016; 11(4):e0153358. PMC: 4829252. DOI: 10.1371/journal.pone.0153358. View

11.

Mori T, Nagai K, Mori M, Nagao M, Imamura M, Iijima M . Progressive liver fibrosis in late-onset argininosuccinate lyase deficiency. Pediatr Dev Pathol. 2002; 5(6):597-601. DOI: 10.1007/s10024-002-0109-7. View

12.

Schlune A, Vom Dahl S, Haussinger D, Ensenauer R, Mayatepek E . Hyperargininemia due to arginase I deficiency: the original patients and their natural history, and a review of the literature. Amino Acids. 2015; 47(9):1751-62. DOI: 10.1007/s00726-015-2032-z. View

13.

Janiec D, Jacobson E, Freeth A, Spaulding L, Blaszyk H . Histologic variation of grade and stage of non-alcoholic fatty liver disease in liver biopsies. Obes Surg. 2005; 15(4):497-501. DOI: 10.1381/0960892053723268. View

14.

Kolker S, Valayannopoulos V, Burlina A, Sykut-Cegielska J, Wijburg F, Leao Teles E . The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 2: the evolving clinical phenotype. J Inherit Metab Dis. 2015; 38(6):1059-74. DOI: 10.1007/s10545-015-9840-x. View

15.

Koo M, Lipshutz G, Cederbaum S, Lassman C . Biopsy-proven Hepatocellular Carcinoma in a 53-year-old Woman With Arginase Deficiency. Pediatr Dev Pathol. 2017; 20(6):517-521. DOI: 10.1177/1093526617697058. View

16.

Estey M, Cohen A, Colantonio D, Chan M, Marvasti T, Randell E . CLSI-based transference of the CALIPER database of pediatric reference intervals from Abbott to Beckman, Ortho, Roche and Siemens Clinical Chemistry Assays: direct validation using reference samples from the CALIPER cohort. Clin Biochem. 2013; 46(13-14):1197-219. DOI: 10.1016/j.clinbiochem.2013.04.001. View

17.

Lin Z, Xin Y, Dong Q, Wang Q, Jiang X, Zhan S . Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis. Hepatology. 2011; 53(3):726-36. DOI: 10.1002/hep.24105. View

18.

Siegel M, Freeman A, Ye W, Palermo J, Molleston J, Paranjape S . Heterogeneous Liver on Research Ultrasound Identifies Children with Cystic Fibrosis at High Risk of Advanced Liver Disease: Interim Results of a Prospective Observational Case-Controlled Study. J Pediatr. 2020; 219:62-69.e4. PMC: 7096278. DOI: 10.1016/j.jpeds.2019.12.033. View

19.

Yucel H, Kasapkara C, Akcaboy M, Aksoy E, Sahin G, Derinkuyu B . Recurrent hepatic failure and status epilepticus: an uncommon presentation of hyperargininemia. Metab Brain Dis. 2018; 33(5):1775-1778. DOI: 10.1007/s11011-018-0281-8. View

20.

Colloredo G, Guido M, Sonzogni A, Leandro G . Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease. J Hepatol. 2003; 39(2):239-44. DOI: 10.1016/s0168-8278(03)00191-0. View